Gardasil
Gardasil is promoted as a cervical cancer vaccine.
Gardasil, manufactured by Merck, Inc., is promoted as the only cervical cancer vaccine that helps protect against four kinds of human papillomavirus (HPV), the virus said to cause cervical cancer. Gardasil is promoted as protection against types 6, 11, 16 and 18, which includes two types that cause 70 percent of cervical cancer cases, and two more types that cause 90 percent of genital warts cases.
Gardasil is marketed to be given to girls and young women as young as age 9, and up to age 26.
Since Gardasil’s introduction in 2006, the Vaccine Adverse Event Reporting System (VAERS) has received more than 20,000 reports of adverse side effects reportedly related to Gardasil. These reports include serious adverse side effects including Guilliane Barre, lupus, seizures, rheumatoid arthritis, and multiple sclerosis, among others. There also have been 92 reported deaths among girls who received the Gardasil vaccine.
On Oct. 16, 2009, the FDA also granted approval to Merck to expand the use of Gardasil in the U.S. to treat boys and men ages 9-26 for the prevention of genital warts.
On October 25, 2009, Dr. Diane Harper, lead researcher in the development of two human papilloma virus (HPV) vaccines and director of the Gynecologic Cancer Prevention Research Group at the University of Missouri, told an audience of medical professionals that Gardasil is largely unnecessary, and that it has never been fully tested on females under the age of 15. This, despite strong marketing efforts to make the drug mandatory for girls, and product literature and advertising that state the product can be used by girls as young as age 9.
do you need a gardasil lawyer?
If you or a loved one have suffered serious side effects while taking Gardasil, you may have a claim against the manufacturer .
Please contact us today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost no-obligation evaluation of your case.
Merck’s Gardasil human paillomavirus (HPV) vaccine could pose a significant health threat to the public because the U.S. Food and Drug Administration (FDA) relied on guesswork when it approved the drug, says Dr. Hanan Polansky of the Center for the Biology of Chronic Disease (CBCD), a not-for-profit organization devoted to understanding the underlying causes of cancer and other systemic diseases.
When French leaders voted to halt the sale and distribution of Merck’s human papilllomavirus (HPV) vaccine in France pending the results of a risk-benefit analysis, they said a number of questions about the vaccine remained unanswered. One of those questions involves 
The distribution of Merck’s human papillomavirus (HPV) vaccine Gardasil has been halted in France, where a government-appointed group of immunologists and other researchers has been formed to determine if the benefits of the vaccine are worth the risks.